PARP9 in viral infections have been associated with promoting type I IFN–mediated antiviral immunity (7, 9, 10) However, a key finding in our in vivo and in vitro studies using a highly relevant bacterial pathogen such as M. tuberculosis showed a contrasting role for PARP9 in M. tuberculosis host immunity. The gene discussed is PARP9; the disease is viral infectious disease.